Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group

scientific article published on 01 May 1996

Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8619763

P433issue5
P921main subjecteye diseaseQ3041498
P1104number of pages10
P304page(s)545-554
P577publication date1996-05-01
P1433published inJAMA OphthalmologyQ4787301
P1476titleRisk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group
P478volume114

Reverse relations

cites work (P2860)
Q80541296807C/T polymorphism in platelet glycoprotein Ia gene is not associated with retinal vein occlusion
Q36586154A longitudinal analysis of risk factors associated with central retinal vein occlusion
Q34864758A patient with acute macular neuroretinopathy and central retinal vein occlusion
Q38869809An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients.
Q30382208Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion
Q52584491Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2).
Q35578994Association between retinal vein occlusion, axial length and vitreous chamber depth measured by optical low coherence reflectometry
Q38376975Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
Q33711660Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Q39761899Blinding bilateral hyperviscosity retinopathy in a 43-year-old nigerian male with lymphoplasmacytic lymphoma: a case report and management challenges
Q43286564Cardiovascular risk factors and outcome in patients with retinal vein occlusion
Q46366389Cavernous sinus thrombosis elicited by a central retinal vein venous stasis retinopathy
Q38521654Central retinal vein occlusion resulting from anomalous retinal vascular anatomy in a 24-year-old man.
Q37338461Central retinal vein occlusion: a case report and review of the literature
Q92174371Clinical Characteristics of Patients With CRVO in One Eye With Subsequent RVO in The Fellow Eye: A Retrospective Observational Study
Q35589694Clinical characteristics of retinal venous occlusions occurring at different sites
Q33774801Clinical progress in impending central retinal vein occlusion
Q37417708Combined cilioretinal artery and central vein occlusions in juvenile glaucoma
Q37116742Comorbidities in combined retinal artery and vein occlusions
Q37361031Comparison between glaucomatous and non-glaucomatous eyes with unilateral retinal vein occlusion in the fellow eye.
Q92498322Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion
Q60927253Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion
Q35099333Comprehensive Review of the Effects of Diabetes on Ocular Health
Q89970136Diabetes mellitus as a risk factor for retinal vein occlusion: A meta-analysis
Q35407942Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity
Q42735697Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female
Q58110582Evaluating the neuroprotective effect of 17β-estradiol in rodent models of oxidative retinopathies
Q30503125Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year
Q37376288Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy
Q28078201Guidance for the management of venous thrombosis in unusual sites
Q24815630Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion
Q35846918INITIAL EXPERIENCE WITH TRANSPUPILLARY DIODE LASER PHOTOCOAGULATION FOR RETINAL DISEASES.
Q36802033Inflammation in retinal vein occlusion
Q35094088Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion
Q35590626Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion
Q33628064Intense exercise causing central retinal vein occlusion in a young patient: case report and review of the literature
Q35908514Intraocular Pressure Reduction Is Associated with Reduced Venous Pulsation Pressure.
Q60915689Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Q24187275Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion
Q33844950Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms
Q64080373Management of the open angle glaucoma in patients with central/hemicentral retinal vein occlusions
Q48357210Measurement of lamina and prelaminar thicknesses of both eyes in patients with unilateral branch retinal vein occlusion.
Q36842136Ocular associations of diabetes other than diabetic retinopathy
Q35967871Ocular tissue responses to sex hormones
Q40421525Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study
Q35867717Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center
Q41595073Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study
Q73482769Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion
Q55283872Recent advances in understanding and managing retinal vein occlusions.
Q92534595Retinal capillary hemangioblastoma and hemiretinal vein occlusion in a patient with primary congenital glaucoma: A case report
Q37170512Retinal vascular changes in hypertensive patients in Ibadan, Sub-Saharan Africa
Q37174819Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
Q24596993Retinal vein occlusion: pathophysiology and treatment options
Q37872641Retinal vein occlusions: a review for the internist
Q42339098Retinal vein pulsation predicts increasing optic disc excavation
Q34604239Retino-choroidal ischemia in central retinal vein occlusion
Q30835869Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data
Q36838150Risk of Retinal Vein Occlusion Following End-Stage Renal Disease
Q39114176Role of Lipids in Retinal Vascular and Macular Disorders.
Q33402708SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion
Q33484531SCORE Study report 3: study design and baseline characteristics
Q46169738SCORE2 Report 2: Study Design and Baseline Characteristics
Q92642574Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus
Q99565681Spinal cord infarction associated to retinal vein occlusion in a patient with chronic kidney disease
Q36188910Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion
Q37669502Systemic abnormalities associated with retinal vein occlusion in young patients
Q36452434The future of glaucoma clinics
Q34795992The incidence of retinal vein occlusion in the ocular hypertension treatment study
Q36276933The relation between exercise and glaucoma in a South Korean population-based sample
Q91905966The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions
Q53608866The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors.
Q36490483Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion
Q36014793Value of retinal vein pulsation characteristics in predicting increased optic disc excavation
Q41110296Vascular Occlusions following Ocular Surgical Procedures: A Clinical Observation of Vascular Complications after Ocular Surgery.
Q33572207Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
Q46523816Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy
Q24813398Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases
Q83095992[Ophthalmological findings as a hint for systemic disease]
Q80307436[Radial optic neurotomy: efficacy monitoring using venous ophthalmodynamometry]
Q83348014[Thrombophilic and systemic risk factors in patients with retinal vein occlusion]

Search more.